Clinical Trial Update: Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating personalized long-term antiplatelet therapy (RAPID EXTEND) in patients with coronary artery disease and prior myocardial infarction h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Disease, Myocardial Infarction | Phase 4 | Status: SUSPENDED